Contact number
+33 1 81 69 15 00Provided by Chambers
McDermott Will & Emery is a well-reputed life sciences practice with a client base spanning domestic and foreign pharmaceutical companies, biotechnology developers and investment funds. The law firm provides a diverse range of advice encompassing research partnership agreements, licensing deals and medical technology development. The team frequently acts in cross-border cases.
Provided by McDermott Will & Emery LLP
McDermott Will & Emery advised Novartis on the sale of CellforCure and its cell and gene therapy development and production site in France to Seqens.
Provided by Chambers
The team give responses adapted to the case at hand while taking into account the business challenges.
I appreciate the dynamism, motivation and transparency that the team demonstrates while ensuring a great rigour that allows it to offer a customer experience that is both personalised and reliable.
I like the good complementarity between the different team members, the ability to quickly mobilise resources and the good network with other firms abroad.
They have a very good understanding of the issues. They are very pragmatic and business-minded.
It is a multidisciplinary team that covers all needs, with a true knowledge of the medtech and biotech sectors and the ability to analyse situations in detail.
The team give responses adapted to the case at hand while taking into account the business challenges.
I appreciate the dynamism, motivation and transparency that the team demonstrates while ensuring a great rigour that allows it to offer a customer experience that is both personalised and reliable.
I like the good complementarity between the different team members, the ability to quickly mobilise resources and the good network with other firms abroad.
They have a very good understanding of the issues. They are very pragmatic and business-minded.
It is a multidisciplinary team that covers all needs, with a true knowledge of the medtech and biotech sectors and the ability to analyse situations in detail.
Provided by Chambers
Emmanuelle Trombe is widely recognised as a leading corporate practitioner in the pharmaceutical and life sciences sectors, with outstanding expertise in acquisitions, financing rounds and licensing agreements
She is always calm, even in tense situations. She can take a step back.
She is very business-oriented and pragmatic.
Emmanuelle is one of the best specialists in the healthcare industry in France. She is able to handle all types of transactions with her team efficiently.
Emmanuelle is a very good negotiator who immediately grasps the most important issues.
She shows great finesse in her support and in her understanding of the most complex issues.
Anthony Paronneau boasts experience in M&A transactions and licensing matters. He is highly sought after by biotech startups.
He always gives very good advice and is very pragmatic on the approach to cases and negotiations.
Anthony Paronneau stands out for his skills and availability. His personality is just as remarkable, as he approaches each problem with calm, rigour and seriousness.
He knows how to simplify the most complex problems.
Anthony is very knowledgeable about the sector, very relatable and accessible.
Anthony is a great lawyer on all fronts: clear in his explanations, practically-minded in regards to his approach to the real world of business, and able to think quickly on his feet.
Up-and-coming partner Anne-France Moreau handles M&A mandates in the pharma sector, including private equity transactions.
We have a very good relationship with Anne-France, who knows how to give good advice on varied and complex cases.
Anne-France is pragmatic and has a strong business mind. Her expertise in biotech is appreciated. It is a real pleasure to work with her and her team.